Regular Article
Leu143 in the Putative Fourth Membrane Spanning Domain Is Critical for Amiloride Inhibition of an Epithelial Na+/H+ Exchanger Isoform (NHE-2)

https://doi.org/10.1006/bbrc.1993.1656Get rights and content

Abstract

A family of Na+/H+ exchanger isoforms (called NHE1, NHE2, and NHE3) which exhibits a wide range of amiloride sensitivity has recently been cloned and characterized. A part of the domain, which determines amiloride sensitivity in the epithelial Na+/H+ exchanger isoform, NHE2, was identified by site-directed mutagenesis and functional studies using cDNAs stably expressed in a fibroblast cell line. It has previously been reported that AR300, an amiloride resistant mutant of the ubiquitous Na+/H+ exchanger isoform, NHE1, is 30-fold more resistant to methylpropyl amiloride (MPA) compared to NHE1 and contains a single amino acid substitution of L167F in the fourth putative transmembrane helix, which corresponds to L143 in NHE2. Therefore, in the present study point mutational substitutions were introduced into the equivalent of this fourth transmembrane helix of rabbit NHE2 (including Y144F; L143F; L143F and Y144F) to mimic the corresponding amino acids in NHE1, NHE3 (another epithelial isoform) and AR300, respectively. NHE2/L143F (mimicking NHE3) increased the IC50 for amiloride by 5-fold and for ethylisopropyl amiloride (EIPA) by 20-fold. Similarly, NHE2/L143F and Y144F (mimicking AR300) increased the resistance to both amiloride and EIPA by 10-fold. On the other hand, NHE2/Y144F (mimicking NHE1) did not affect the sensitivity to amiloride or EIPA, and this mutant, like wild type NHE2, is partially resistant to EIPA. Thus, amino acid 143 of NHE2 is critical for, but is not the only amino acid responsible for, amiloride and EIPA inhibition of Na+/H+ exchange. That none of the mutations studied altered the Na+ affinity of these Na+/H+ exchangers further suggests that amiloride binding and Na+ transport sites are not identical.

References (0)

Cited by (44)

  • Characterization of modeled inhibitory binding sites on isoform one of the Na<sup>+</sup>/H<sup>+</sup> exchanger

    2021, Biochimica et Biophysica Acta - Biomembranes
    Citation Excerpt :

    Additionally, changes in amiloride sensitivity can be accompanied by differences in Na+ kinetics however changes in amiloride sensitivity can also occur without changes in Na+ affinity [30,31]. Different resistance between different NHE isoforms is noted despite similar Na+ kinetics and large changes in NHE1 inhibition can be made more resistant by mutation, despite having Na+ transport unaltered [36,45]. Taken together the results suggest a complex relationship between inhibitor binding sites and Na+, they may be distinct and either cooperative or partially overlapping sites.

  • Molecular characterization, cellular localization, and light-enhanced expression of Beta-Na <sup>+</sup> /H <sup>+</sup> Exchanger-like in the whitish inner mantle of the giant clam, Tridacna squamosa, denote its role in light-enhanced shell formation

    2019, Gene
    Citation Excerpt :

    This rendered the protein a 30-fold increase in resistance to the amiloride analog, methylpropyl amiloride. Likewise, when Leu143 was mutated to phenylalanine in mammalian NHE2 (L143F), the transporter displayed a 5-fold greater resistant to amiloride than the wild-type NHE2 (Yun et al., 1993). Hence, the retention of NHE1 attributes with its own distinctive regulatory properties in βNHE-like of T. squamosa gives further support to its identity.

  • Structural dynamics and regulation of the mammalian SLC9A family of Na<sup>+</sup>/H<sup>+</sup> exchangers

    2014, Current Topics in Membranes
    Citation Excerpt :

    A NHE3-specific inhibitor, S3226 (Ki = 0.02 μM for NHE3, 3.6 μM for NHE1) also exists (Schwark et al., 1998). A number of mutagenesis studies have addressed the mechanisms by which these inhibitors interact with NHE1, in particular, residues in TMIV and TMIX–TMXI appear to be important for the interaction, consistent with the partially competitive nature of NHE inhibition by these compounds (Counillon, Franchi, & Pouyssegur, 1993; Khadilkar, Iannuzzi, & Orlowski, 2001; Orlowski & Kandasamy, 1996; Pedersen, King, Nygaard, Rigor, & Cala, 2007; Touret, Poujeol, & Counillon, 2001; Yun et al., 1993). Very early it was recognized that NHEs encompass a large membrane embedded part with a suggested topology of 10–13 TM segments of helical character (Orlowski, Kandasamy, & Shull, 1992; Rothman, Padan, & Schuldiner, 1996; Sardet, Franchi, & Pouyssegur, 1989; see Wakabayashi, Ikeda, et al., 1997; Wakabayashi, Shigekawa, et al., 1997).

  • NHE1 inhibition by amiloride- and benzoylguanidine-type compounds: Inhibitor binding loci deduced from chimeras of NHE1 homologues with endogenous differences in inhibitor sensitivity

    2007, Journal of Biological Chemistry
    Citation Excerpt :

    Previous studies have largely addressed this question based on the identification of point mutations associated with reduced inhibitor sensitivity in the mammalian NHE1. These studies primarily point to regions in TM4 and TM9 as important for inhibitor sensitivity (15, 17, 18, 20–22, 33). In loss-of-function studies, however, it is difficult to distinguish between a direct role of the amino acids in question and global changes resulting in deterioration of protein integrity.

  • Identification of Sites in the Second Exomembrane Loop and Ninth Transmembrane Helix of the Mammalian Na<sup>+</sup>/H<sup>+</sup> Exchanger Important for Drug Recognition and Cation Translocation

    2001, Journal of Biological Chemistry
    Citation Excerpt :

    We also corroborated earlier findings that replacement of Leu167 with Phe (present at the equivalent position of NHE3) in M4 also significantly reduced drug sensitivity (30). Indeed, this site seems to be generally important for drug recognition by the NHEs, since mutagenesis of the equivalent residue in rabbit NHE2 (L143F) also reduced its sensitivity to amiloride compounds (44). To further confirm the involvement of transmembrane helices M4 and M9 in drug recognition, we combined the L167F and G356A mutations.

View all citing articles on Scopus
View full text